Levodopa and melanoma.
D004156:Catechol Oxidase / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008544:Melanocytes / Q000187:drug effects; D008545:Melanoma / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy; D012867:Skin / Q000201:enzymology; D014443:Tyrosine
D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D004156:Catechol Oxidase